NCT03521024 is a NA clinical trial of poly ether ketone ketone in Tooth Loss, sponsored by Cairo University.

Who is sponsoring NCT03521024?

NCT03521024 is sponsored by Cairo University.

What drugs are being tested in NCT03521024?

Interventions in NCT03521024: poly ether ketone ketone, lithium disilicate.

What condition does NCT03521024 study?

NCT03521024 studies Tooth Loss.

Is NCT03521024 still recruiting?

NCT03521024 is currently status unknown. Last updated 11 May 2018.

Last reviewed 2018-05-11 · How we verify

NCT03521024

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Zirconia Implant Supported PEKK Crowns Versus Lithium Disilicate Crowns on Esthetics

Status unknown NA Last updated 11 May 2018

What this trial tests

NA trial testing poly ether ketone ketone in Tooth Loss in 10 participants. Status unknown.

Timeline

15 September 2018

Primary endpoint
15 June 2019

15 September 2019

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	10
Start date	15 September 2018
Primary completion	15 June 2019
Estimated completion	15 September 2019

Drugs / interventions tested

poly ether ketone ketone
lithium disilicate

Conditions studied

Tooth Loss — all drugs for Tooth Loss →

Sponsor

Cairo University

Who can join

Adults 18 to 45, any sex, with Tooth Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

aim of study is to evaluate esthetic and biomechanical outcome of maxillary anterior single-tooth zirconia implant supported PEKK crowns compared to lithium disilicate crowns on PEKK abutments .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Tooth Loss

Currently open trials in the same condition.

NCT07393997 — Autogenous Tooth Transplantation With Instrumentally Simulated Open Apex and Platelet-Rich Fibrin · NA · recruiting
NCT07280260 — Clinical Performance of Nobel N1 System · Phase 4 · recruiting
NCT07177521 — Primary Stability and Peri-implant Outcomes of Short Implants in Post-extraction Single-tooth Sites · NA · recruiting
NCT07534514 — Digitally Assisted Immediate Implants in Geriatric Patients · recruiting
NCT06554080 — Survival and Success Rates of External- and Internal- Connection Dental Implants Placed Within the United Kingdom Armed · active not recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03521024 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 11 May 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03521024.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing